United States· US:24208-344_103e2cf8-62f9-4911-995b-444bde83bcf6
Flunisolide
A flunisolide product containing flunisolide, registered in United States by Bausch & Lomb Incorporated. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Flunisolide is registered in 5 of 19 countries.
Countries holding a registration under ATC R01AD04 (flunisolide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Flunisolide · ATC R01AD04
5 / 19 countries
- Finlandprice
- Germany
- Italyprice
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLUNISOLIDE
- Manufacturer
- Bausch & Lomb Incorporated
- Country
- United States (US)
- ATC code
- R01AD04
- ATC class
- Flunisolide
- Defined daily dose
- 0.15 mg, N
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1124208344251 BOTTLE, PUMP in 1 CARTON (24208-344-25) / 25 mL in 1 BOTTLE, PUMP
- ndc1124208-344-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
38 interactions on record for flunisolide.
Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flunisolide · interactions on record
38 records
- 38 moderate
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flunisolide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyAERFLUS.F. GROUP S.R.L.
- United KingdomFlunisolide 25micrograms/dose nasal spraySpecial Order
- GermanySyntarisDermapharm Ag
- NorwaySyntarisDermapharm
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Syntaris
- Italy · Aerflu, Aerflu Adulti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7da63ec-171a-4208-9c60-ebd42a9db262 GET /v1/drugs/f7da63ec-171a-4208-9c60-ebd42a9db262?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"source": "ndc",
"strength": ".25",
"substance": "FLUNISOLIDE",
"productndc": "24208-344",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA074805",
"marketing_category": "ANDA"
}See everything about flunisolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.